New risk score helps predict pancreatic cancer recurrence

Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients with pancreatic neuroendocrine tumors (PanNETs) need closer monitoring because their cancer is more likely to recur.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup